GlassScriptPhysician profile
Steven M Huffman
NPI 1275585614
$516.84
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.97 · 2020: $88.40 · 2023: $148 · 2024: $60.09 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $147.69 | 2023 | |
| Becton, Dickinson and Company | $81.48 | 2025 | Hemosphere |
| Medtronic, INC. | $57.27 | 2024-2025 | Bis |
| Endo Pharmaceuticals INC. | $48.11 | 2020 | |
| Edwards Lifesciences Corporation | $41.78 | 2019 | |
| Merck Sharp & Dohme LLC | $30.37 | 2019-2024 | Bridion |
| Mallinckrodt Hospital Products INC. | $26.68 | 2020 | |
| Covidien LP | $20.39 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $19.47 | 2025 | Neffy |
| Fisher & Paykel Healthcare INC | $16.23 | 2025 | Fisher & Paykel Healthcare |
| Avanos Medical | $13.76 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $13.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.